Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children

S. M. Hanash, R. Kuick, J. Strahler, B. Richardson, G. Reaman, L. Stoolman, C. Hanson, D. Nichols, H. J. Tueche

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.

Original languageEnglish (US)
Pages (from-to)527-532
Number of pages6
JournalBlood
Volume73
Issue number2
StatePublished - 1989
Externally publishedYes

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Peptides
HLA-DR Antigens
Electrophoresis
Chemical analysis
Electrophoresis, Gel, Two-Dimensional
Phenotype

ASJC Scopus subject areas

  • Hematology

Cite this

Hanash, S. M., Kuick, R., Strahler, J., Richardson, B., Reaman, G., Stoolman, L., ... Tueche, H. J. (1989). Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. Blood, 73(2), 527-532.

Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. / Hanash, S. M.; Kuick, R.; Strahler, J.; Richardson, B.; Reaman, G.; Stoolman, L.; Hanson, C.; Nichols, D.; Tueche, H. J.

In: Blood, Vol. 73, No. 2, 1989, p. 527-532.

Research output: Contribution to journalArticle

Hanash, SM, Kuick, R, Strahler, J, Richardson, B, Reaman, G, Stoolman, L, Hanson, C, Nichols, D & Tueche, HJ 1989, 'Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children', Blood, vol. 73, no. 2, pp. 527-532.
Hanash SM, Kuick R, Strahler J, Richardson B, Reaman G, Stoolman L et al. Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. Blood. 1989;73(2):527-532.
Hanash, S. M. ; Kuick, R. ; Strahler, J. ; Richardson, B. ; Reaman, G. ; Stoolman, L. ; Hanson, C. ; Nichols, D. ; Tueche, H. J. / Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. In: Blood. 1989 ; Vol. 73, No. 2. pp. 527-532.
@article{0bed237f03c2462f81ce5f5e7602929c,
title = "Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children",
abstract = "We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.",
author = "Hanash, {S. M.} and R. Kuick and J. Strahler and B. Richardson and G. Reaman and L. Stoolman and C. Hanson and D. Nichols and Tueche, {H. J.}",
year = "1989",
language = "English (US)",
volume = "73",
pages = "527--532",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children

AU - Hanash, S. M.

AU - Kuick, R.

AU - Strahler, J.

AU - Richardson, B.

AU - Reaman, G.

AU - Stoolman, L.

AU - Hanson, C.

AU - Nichols, D.

AU - Tueche, H. J.

PY - 1989

Y1 - 1989

N2 - We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.

AB - We analyzed the polypeptide pattern of leukemic cells of infants and older children with acute lymphoblastic leukemia (ALL), using two-dimensional polyacrylamide gel electrophoresis (PAGE). Patterns were analyzed for the occurrence of a previously detected cytosolic polypeptide, designated L3. Quantitative analysis of L3 in 12 infants and 91 older children with non-T ALL indicated lack of expression of polypeptide L3 in leukemic cells of infants which, in most cases, expressed HLA-DR and CD19 and lacked CD10. Quantitative analysis of L3 in relation to cell surface marker expression revealed that L3 was limited in its occurrence to non-T ALL and was not coordinately expressed with any of the surface markers included in the study. Among patients in the HLA-DR-positive, CD19-positive, and CD10-negative group, different levels of polypeptide L3 were observed between infants and older children. These results indicate differences in leukemic cell constituents between infants and older children with ALL and an otherwise similar cell surface marker phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0024504007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024504007&partnerID=8YFLogxK

M3 - Article

C2 - 2917188

AN - SCOPUS:0024504007

VL - 73

SP - 527

EP - 532

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -